About this trial
To investigate the relationship between the hematological indices and subclinical inflammation in FMF patients during their attack-free period, additionally this study aims to assess the potential of these indices as predictive markers for ongoing inflammation in these patients population at Assuit university hospital of pediatrics.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age at enrollment less than18 years.
Both sexes.
Diagnosed as familial Mediterranean fever according to Tel-Hashomer criteria in pediatrics and Eurofever /PRINTO criteria
Disqualifiers
None
Trial population
Their clinical presentation and laboratory finding should fulfill the diagnostic criteria as mentioned by Tel Hashomer criteria in pediatrics (≥2 criteria) and Eurofever /PRINTO criteria (≥6 criteria) and confirmed by genetic testing of the most common 12 genetic variants in MEFV gene
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
investigate the association of haematological indices with subclinical inflammation
investigate the association of hematological indices with subclinical inflammation and to evaluate their usability as predictors of ongoing inflammation in FMF patients during their attack-free period in Assiut university hospital and to describe the clinical characteristics of patients diagnosed as FMF in Upper Egypt, and to find the most common presenting symptoms.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: